The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Regulatory News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.25
Bid: 15.00
Ask: 15.50
Change: -0.25 (-1.61%)
Spread: 0.50 (3.333%)
Open: 15.00
High: 15.50
Low: 14.65
Prev. Close: 15.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further information re Director's share transfer

12 Nov 2014 07:00

RNS Number : 7990W
Angle PLC
12 November 2014
 



For immediate release

12 November 2014

 

ANGLE plc

("ANGLE" or the "Company")

 

Further information re Director's share transfer

 

On 21 October 2014, the Company announced that Andrew Newland, Chief Executive of ANGLE, had agreed to transfer up to 3,500,000 ordinary shares of 10p each in the Company ("Ordinary Shares") as security for a loan facility in connection with his moving house (the "Announcement").

 

Following recent comments in the media relating to the Announcement, the Company wishes to provide the following information.

 

The agreement was entered into with Equity First Holdings LLC ("EFH") (the "Agreement") and, under the Agreement, which is a sale and repurchase agreement intended to provide financing to Andrew Newland, he transferred the legal and beneficial interest in 1,350,000 Ordinary Shares to EFH (the "transferred shares") in return for him receiving a payment from EFH of a sum equal to 62 per cent. of the three-day average mid-price per share (the "Starting Market Price") less a financing arrangement fee of 2 per cent.. Further details of the transfer made are set out below. As the legal and beneficial holder of the transferred shares, EFH may take any action it deems appropriate in relation to the transferred shares and is under no obligation to hold or retain the transferred shares.

 

On the maturity date of the Agreement (27 October 2016), Andrew Newland is contractually obliged to purchase the transferred shares or equivalent Ordinary Shares from EFH at a price equal to 67 per cent. of the Starting Market Price and EFH is contractually obliged to deliver the transferred shares or equivalent Ordinary Shares to Andrew Newland on payment.

 

If, prior to the maturity date, the value of the transferred shares falls to 49.6 per cent. or less of the Starting Market Price, Andrew Newland will be required to transfer further Ordinary Shares or provide cash to cover any difference.

 

The summary below is a clarification and correction of certain information contained in the Announcement. Andrew Newland remains interested in the transferred shares by reason of the repurchase obligation contained in the Agreement. Further announcements will be made if any further Ordinary Shares are transferred pursuant to the Agreement.

 

· Number of Ordinary Shares prior to transfer of shares under facility 7,054,686

· Number of Ordinary Shares transferred to EFH pursuant to the facility (and to be repurchased) to date 1,350,000

· Starting Market Price £0.851

· Number of Ordinary Shares with voting rights held after transactions and as a % of the Company 5,704,686 (12.61%)

· Total interest in Ordinary Shares and as a % of the Company(1) 7,054,686 (15.59%)

 

(1) As stated above, under the Agreement, Andrew Newland has agreed to repurchase the transferred shares or equivalent Ordinary Shares at the end of the two year period at a price calculated by reference to the Starting Market Price. For this reason he continues to have an interest in these Ordinary Shares and they are therefore included in his total interest in Ordinary Shares.

 

 

Garth Selvey, Chairman of ANGLE, commented: "Andrew has entered into this finance arrangement to bridge the purchase and renovation of a new house. Andrew believes strongly in the future value of ANGLE and does not want to sell his shares into the market. This facility enables him to return to his original position once the facility is repaid."

 

 

For further information:

 

ANGLE plc

01483 685830

Andrew Newland, Chief Executive

Ian Griffiths, Finance Director

 

Cenkos Securities

Stephen Keys, Dr Christopher Golden (Nominated adviser)

Andy Roberts, Christian Hobart (Sales)

 

020 7397 8900

Buchanan

Mark Court, Sophie Cowles

020 7466 5000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMMMMVZRGDZG
Date   Source Headline
9th Jan 200712:57 pmRNSNotice of Results
21st Dec 20064:12 pmRNSTotal Voting Rights
29th Nov 20062:23 pmBUSSerial Entrepreneur Jothy Rosenberg Joins ANGLE Technology Ventures
27th Nov 20061:49 pmRNSContract Award
8th Sep 20067:01 amRNSNon-Executive Appointment
7th Sep 20062:26 pmRNSAGM Statement
28th Jul 200610:37 amRNSDirector/PDMR Shareholding
27th Jul 20067:02 amRNSPreliminary Results
27th Jul 20067:00 amRNSStrategic Partnership
27th Jul 20067:00 amRNSGeomerics IP Validation
17th May 20067:00 amRNSNew Venture Company
15th May 20064:55 pmRNSHolding(s) in Company
8th May 20068:52 amRNSHolding(s) in Company
4th May 20067:01 amRNSNew Venture - Parsortix Inc
5th Apr 20061:54 pmRNSHolding(s) in Company
31st Mar 20063:54 pmRNSBoard Change
31st Mar 20063:52 pmRNSHolding(s) in Company
29th Mar 200611:45 amRNSEGM Statement
29th Mar 20067:02 amRNSNew Venture Company
6th Mar 20067:02 amRNSPlacing
24th Jan 20067:01 amRNSChange of Adviser
24th Jan 20067:01 amRNSContract Extension
24th Jan 20067:01 amRNSInterim Results
16th Dec 20052:32 pmRNSSnr Appt at Geomerics
17th Nov 20057:02 amRNSRe US Venture -- Aberro
15th Nov 20057:03 amRNSRe Synature Ltd
11th Nov 20057:29 amRNSAppointment at Novocellus Ltd
2nd Nov 20059:41 amRNSDirector/PDMR Shareholding
25th Oct 20058:00 amRNSAppointments - UK Ventures
20th Oct 20057:00 amRNSContract Extension
17th Oct 20057:01 amRNSVentures (US) Team Expansion
1st Sep 200512:43 pmRNSHolding(s) in Company
25th Aug 20053:02 pmRNSResult of AGM
11th Aug 20055:21 pmRNSAdditional Listing
1st Aug 20057:01 amRNSDirectorate Change
20th Jul 20058:30 amRNSContract Win
6th Jul 20057:01 amRNSFinal Results
24th Jun 20058:00 amRNSRe Provexis Admission to AIM
23rd Jun 20053:13 pmRNSNotice of Results
22nd Jun 200512:45 pmRNSHolding(s) in Company
10th Jun 20057:01 amRNSJoint Research Programme
31st May 20057:02 amRNSRe Acolyte Biomedica
26th May 20057:02 amRNSTrading Update
26th May 20057:02 amRNSProvexis - Reverse Takeover
6th May 20057:00 amRNSGeomerics - New Venture Co.
29th Apr 20057:01 amRNSNew US Venture
12th Apr 20057:00 amRNSNew Contracts
23rd Mar 200512:03 pmRNSRe Provexis Limited
21st Mar 20058:51 amRNSAdditional Listing
10th Mar 200512:06 pmRNSDirector Appt to UK Ventures

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.